2024-11-19 17:50:59
Novartis receives approval for Kymriah (tisagenlecleucel) by Health Sciences Authority as Singapore's first commercially approved CAR-T therapy
Health/ 2023-07-22
Novartis receives approval for Kymriah (...

Kymriah,the first chimeric antigen receptor T-cell (CAR-T) therapy approved in Singapore,is indicated as a one-time treatment manufactured i...

Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs
Corporate/ 2023-07-23
Insilico's Chemistry42 AI system in...

HONG KONG,March 9,2021--Insilico Medicine,an AI drug discovery company,announced that UCB will integrate Insilico\'s Chemistry42™ into UCB\...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release